DNAVision
ActiveFrom the official registers: KBO 22 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
The computed 12-month bankruptcy probability of DNAVision is 2.1% (moderate). The 2025 annual accounts show negative equity (-€879,841) and a net result of -€73,752. Equity is shrinking by about 13% per year across the filed financial years. Its solvency ranks better than 5% of 239 sector peers (NACE 72, financial year 2025). The company has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals.
Register details
Who it is
KBO recordName
DNAVision in French
Enterprise number
0865.300.475
Legal form
Public limited company
Status
Active, normale toestand
Founded
13-05-2004
Type
Legal entity
Where it is based
Registered office
Avenue Georges Lemaitre 25, 6041 Charleroi, Belgium
Establishments
1 establishment unit since 2004
What it does
NACEBEL 202572101
Research and development on biotechnology main activity
72109
Other research and development on natural sciences main activity
Invoicing and payment
VAT number
BE 0865.300.475
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Registered office and establishments
1 establishment unit
DNAVision
since 2004unit no. 2.139.181.877
Buildings and parcels at the address
Ground area
5,399 m²
Parcel 52028B0318/00G002, Wallonia.
1 parcel
Wallonia
1
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 52028B0318/00G002 | Wallonia | 5,399 m² | - | - |